LEAP Study: Early Peanut Introduction Prevents Allergy

ByParent Science Space Editorial
🟢
Peer-Reviewed Research

The LEAP Study: A Shift in Preventing Peanut Allergy

In 2015, the Learning Early About Peanut (LEAP) trial produced a result that changed pediatric guidelines globally. Introducing peanut protein to high-risk infants between 4 and 11 months of age reduced the subsequent development of peanut allergy by 81%. This finding overturned decades of advice to delay allergenic foods and established early introduction as a primary prevention strategy. The 2026 review by Dahdah, Mazzuca, Urbani, and Fiocchi confirms this is now a cornerstone of food allergy prevention, supported by high-certainty evidence.

Why Early Introduction Matters Now

Food allergies affect approximately 8% of children in the United States, with peanut and egg among the most common. Claire King and colleagues from the Center for Food Allergy and Asthma Research note in their 2026 policy analysis that despite the strong evidence from LEAP and subsequent trials, adherence to early introduction guidelines remains low. Barriers include parental anxiety, inconsistent messaging from healthcare providers, and structural issues like lack of insurance coverage for allergy counseling. Implementing this science effectively is a current public health priority with the potential to reduce a significant burden on children and families.

The Cost of Delay

Earlier recommendations, which advised delaying allergenic foods until ages 1-3, lacked evidence and may have contributed to the rise in allergy prevalence over the past two decades. Avoiding a food during the critical window for developing oral tolerance can increase, not decrease, allergy risk. The shift in guidance represents a clear case of science correcting practice.

The Immunological Science Behind Early Introduction

The rationale for early introduction is grounded in two key concepts: the critical window for oral tolerance and the dual-allergen exposure hypothesis.

The Critical Window for Oral Tolerance

Oral tolerance is an active immune process where the body learns to accept food proteins as safe. This process is most effective during a specific developmental period in infancy, roughly between 4 and 11 months of age. Gastrointestinal exposure to allergens during this window promotes regulatory immune responses. Missing this window can make it harder for the immune system to develop tolerance later.

Dual-Allergen Exposure Hypothesis

This hypothesis explains how allergy can develop. It proposes that exposure to food proteins through a compromised skin barrier (like eczema) can lead to allergic sensitization. In contrast, early, regular consumption of the same food protein trains the immune system to tolerate it. The goal of early introduction is to ensure the first substantial exposure happens via the gut, not the skin.

What the Clinical Trials Show

The LEAP study, conducted by Gideon Lack and his team, provided the definitive evidence. It enrolled over 600 infants considered at high risk for peanut allergy due to severe eczema, egg allergy, or both. Infants were randomly assigned to either consume peanut protein regularly or avoid it until age 5. The results were striking: among children who consumed peanut, only 3.2% developed a peanut allergy by age 5, compared to 17.2% in the avoidance group.

Evidence Extends Beyond Peanut

Follow-up studies like LEAP-On showed the protective effect persisted. Trials for other allergens, particularly egg, have reinforced the principle. The PETIT trial demonstrated that introducing heated egg powder to infants with eczema significantly reduced egg allergy prevalence. Meta-analyses now consolidate this as high-certainty evidence for peanut and egg, with emerging data supporting the early introduction of other common allergens.

It is important to acknowledge that most high-quality evidence focuses on infants at high risk for allergy, particularly those with eczema. The benefit for infants with no risk factors is less quantified, though current guidelines recommend early introduction for all infants as a safe and potentially beneficial practice.

Practical Application: How to Introduce Peanuts Safely

Translating the research into home practice requires careful steps to ensure safety. The guidelines differentiate approach based on an infant’s risk level.

Step 1: Assess Infant Risk

The first step is to consult with a pediatrician or healthcare provider before introduction. They will help categorize your infant:

  • High Risk: Infants with severe eczema, egg allergy, or both. These infants should have peanut introduced as early as 4-6 months, after consultation, and likely after an allergy test.
  • Moderate Risk: Infants with mild to moderate eczema. These infants can have peanut introduced around 6 months at home.
  • Low Risk: Infants with no eczema or food allergies. These infants can have age-appropriate peanut-containing foods introduced freely with other solids.

Step 2: Choose the Right Food Form

Whole nuts and thick nut butters are choking hazards. Safe preparation methods include:

  • Thinned peanut butter: Mix 2 teaspoons of smooth peanut butter with 2-3 teaspoons of warm water, breast milk, or formula to create a thin, creamy consistency.
  • Peanut powder: Mix 2 teaspoons of peanut powder with several teaspoons of fruit or vegetable puree.
  • Peanut-containing puffs or melts: Commercially available products designed for infant feeding can be a convenient option.

Step 3: Administer and Monitor

Offer a small amount (about the size of a pea) on the tip of a spoon for the first taste. Wait 10 minutes and observe for any reaction. If no symptoms appear, continue feeding the rest of the serving. Give peanut-containing foods at least three times per week to maintain tolerance. For more information on starting solids safely, see our guide on Baby-Led Weaning Safety.

Policy and Implementation Challenges

The 2026 policy paper by King et al. identifies a significant gap between evidence and practice. Their analysis, stemming from a Food Allergy Summit at Northwestern University, proposes a three-pronged strategy to increase adherence.

Standardizing Clinical Guidelines

Alignment among major medical societies (like the American Academy of Pediatrics) and inclusion of early introduction recommendations in standardized pediatric checklists like Bright Futures can create consistent messaging for all healthcare providers.

Increasing Access Through Insurance

Insurance coverage for preventive allergist consultations and for infant-safe allergen products, especially through programs like WIC (Special Supplemental Nutrition Program for Women, Infants, and Children), can remove financial and logistical barriers for families.

Educating Clinicians and Caregivers

Targeted education campaigns are needed to update healthcare providers on the current evidence and equip them to counsel parents effectively. Clear public-facing materials can help address caregiver concerns about safety and method.

Frequently Asked Questions

What if my baby has severe eczema?

Infants with severe eczema are at highest risk and benefit most from early peanut introduction, but should be evaluated by a pediatrician or allergist first. They may recommend a supervised introduction or allergy testing before you start at home.

Can I just rub peanut butter on my baby’s skin to test for allergy?

No. Skin exposure to allergenic foods before oral introduction may actually increase allergy risk according to the dual-exposure hypothesis. The first significant exposure should always be through eating.

What are the signs of an allergic reaction I should watch for?

Mild to moderate symptoms can include new hives, redness around the mouth, vomiting, or increased fussiness. Severe symptoms like difficulty breathing, swelling of the tongue, or becoming pale and limp require immediate emergency care. Always discuss an emergency plan with your pediatrician.

If my child tolerates peanut at 6 months, are they protected for life?

Regular, continued consumption is necessary to maintain tolerance. The LEAP-On study showed protection persisted after a year of avoidance following the initial trial, but long-term maintenance likely requires keeping peanut in the diet consistently.

Key Takeaways

  • Introducing peanut protein to infants between 4 and 11 months of age can reduce peanut allergy risk by over 80%, especially for those with eczema or egg allergy.
  • The immune system has a critical window in early infancy for developing food tolerance through the gut; delaying introduction misses this opportunity.
  • Always consult a pediatrician before introducing peanuts to a high-risk infant (with severe eczema or existing food allergy).
  • Use safe, non-choking forms like thinned peanut butter or powder and start with a small amount, monitoring for any reaction.
  • For protection to last, peanut should be consumed regularly, at least three times per week, as part of the infant’s diet.
  • Current policy efforts aim to make early introduction guidelines more consistent and accessible to all families through healthcare systems and

    💊 Popular children’s supplements

    Available on iHerb (ships to 180+ countries):

    Kids Multi ↗
    Kids DHA ↗
    Kids Vitamin D3 ↗

    Affiliate disclosure: we may earn a small commission at no extra cost to you.

    Medical Disclaimer

    This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

    ⚡ Research Insider Weekly

    Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

    No spam. Unsubscribe anytime. Powered by Beehiiv.

Similar Posts